Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 18,385 | 13,076 | 12,062 | 13,511 | 14,255 |
| Cost of Goods | 5,758 | 3,137 | 3,387 | 3,121 | 3,386 |
| Gross Profit | 12,627 | 9,939 | 8,675 | 10,390 | 10,869 |
| Operating Expenses | 120,268 | 124,685 | 110,449 | 111,061 | 96,160 |
| Operating Income | -106,883 | -114,609 | -101,387 | -100,550 | -84,905 |
| Interest Expense | 3,249 | 2,942 | 2,900 | 2,016 | 2,366 |
| Other Income | 71,186 | -60,517 | -15,486 | -64,752 | 89,902 |
| Pre-tax Income | -38,946 | -178,068 | -119,773 | -167,318 | 2,631 |
| Income Tax | 1,463 | -33,055 | 386 | -641 | -206 |
| Net Income Continuous | -40,540 | -144,862 | -119,995 | -166,699 | 2,418 |
| Minority Interests | 275 | -445 | -192 | -84 | -92 |
| Net Income | $-40,815 | $-144,417 | $-119,803 | $-166,615 | $2,510 |
| EPS Basic Total Ops | -0.12 | -0.49 | -0.40 | -0.57 | 0.01 |
| EPS Basic Continuous Ops | -0.12 | -0.49 | -0.40 | -0.57 | 0.01 |
| EPS Diluted Total Ops | -0.12 | -0.49 | -0.40 | -0.57 | 0.01 |
| EPS Diluted Continuous Ops | -0.12 | -0.49 | -0.40 | -0.57 | 0.01 |
| EPS Diluted Before Non-Recurring Items | -0.12 | N/A | -0.40 | N/A | N/A |
| EBITDA(a) | $-100,679 | $-102,588 | $-97,840 | $-97,412 | $-81,987 |